Illumina
ILMN · NASDAQ · Biotech, Manufacturing, Genomics · Founded 1998
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Current Price
$235.99
Market Cap
$35.6B
Return Since Last Split
+115%
Last Split
Jun 25, 2024
Total Splits
2
Cumulative Multiple
2.056×
What If You Bought ILMN Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$48,520
206 shares · 2×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jun 25, 2024 | $110.24 | 257-for-250 | 1.028× | 2.056× |
| Sep 23, 2008 | $83.02 | 2-for-1 | 2× | 2× |
Illumina Market Cap Timeline
Market capitalization from public listing to today. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Illumina's latest record in the split calendar is a 257-for-250 forward split effective 2024-06-25.